These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

437 related items for PubMed ID: 22288962

  • 1. Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.
    Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J.
    Arch Pathol Lab Med; 2012 Feb; 136(2):155-62. PubMed ID: 22288962
    [Abstract] [Full Text] [Related]

  • 2. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ, Shin HC, Shin KC, Ro JY.
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [Abstract] [Full Text] [Related]

  • 3. Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray.
    Turner BM, Cagle PT, Sainz IM, Fukuoka J, Shen SS, Jagirdar J.
    Arch Pathol Lab Med; 2012 Feb; 136(2):163-71. PubMed ID: 22288963
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Napsin A and thyroid transcription factor-1 expression in carcinomas of the lung, breast, pancreas, colon, kidney, thyroid, and malignant mesothelioma.
    Bishop JA, Sharma R, Illei PB.
    Hum Pathol; 2010 Jan; 41(1):20-5. PubMed ID: 19740516
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thyroid transcription factor 1 and Napsin A double stain: utilizing different vendor antibodies for diagnosing lung adenocarcinoma.
    Johnson H, Cohen C, Fatima N, Duncan D, Siddiqui MT.
    Acta Cytol; 2012 Jan; 56(6):596-602. PubMed ID: 23207437
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis.
    Nicholson AG, Gonzalez D, Shah P, Pynegar MJ, Deshmukh M, Rice A, Popat S.
    J Thorac Oncol; 2010 Apr; 5(4):436-41. PubMed ID: 20068475
    [Abstract] [Full Text] [Related]

  • 11. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
    van Zyl A, Schubert PT, Koegelenberg CFN.
    Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ribonucleic Acid In Situ Hybridization Is a More Sensitive Method Than Immunohistochemistry in Detection of Thyroid Transcription Factor 1 and Napsin A Expression in Lung Adenocarcinomas.
    Shi J, Liu H, Ma XJ, Chen Z, He MX, Luo Y, Lin F.
    Arch Pathol Lab Med; 2016 Apr; 140(4):332-40. PubMed ID: 27028392
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies.
    Warth A, Muley T, Herpel E, Meister M, Herth FJ, Schirmacher P, Weichert W, Hoffmann H, Schnabel PA.
    Histopathology; 2012 Dec; 61(6):1017-25. PubMed ID: 22882703
    [Abstract] [Full Text] [Related]

  • 16. Role of Napsin A and TTF1 as a diagnostic marker for lung adenocarcinoma.
    Iqbal J.
    Arch Pathol Lab Med; 2013 Feb; 137(2):155. PubMed ID: 23368855
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.
    Khayyata S, Yun S, Pasha T, Jian B, McGrath C, Yu G, Gupta P, Baloch Z.
    Diagn Cytopathol; 2009 Mar; 37(3):178-83. PubMed ID: 19170169
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.